Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Advance care planning in multiple system atrophy: ethical challenges and considerations

    Caroline Breitegger, Florian Krismer, Stefan Lorenzl in Clinical Autonomic Research (2024)

  2. Article

    Open Access

    Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment

    To investigate the contributors to self-rated health in people with late-stage Parkinson’s disease (PD) and cognitive impairment.

    Jennifer S. Pigott, Megan Armstrong, Nathan Davies in Quality of Life Research (2024)

  3. Article

    Open Access

    Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease

    The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In th...

    Anna Sauerbier, Johanna Herberg, Vasilija Stopic in npj Parkinson's Disease (2024)

  4. Article

    Open Access

    Meaning in Life in Late-Stage Parkinson’s Disease: Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries

    The Care of Late-Stage Parkinsonism (CLaSP) study is a longitudinal, multicentre, prospective cohort study to assess the needs and provision of care for people with late-stage Parkinson’s disease and their car...

    Sarah K. Bublitz, Cornelia Brandstötter, Martin Fegg in Journal of Religion and Health (2024)

  5. Article

    Open Access

    Intervention components in the self-management of Parkinson’s: a mixed-methods synthesis of qualitative and quantitative evidence

    Self-management interventions consist of multiple components to support people in the management of medical, emotional, and behavioural aspects of their condition, and aim to improve quality of life, function,...

    Megan Armstrong, Kate Walters, Nathan Davies in BMC Health Services Research (2024)

  6. Article

    Open Access

    Clinical and cost-effectiveness of ‘Live Well with Parkinson’s’ self-management intervention versus treatment as usual for improving quality of life for people with Parkinson’s: study protocol for a randomised controlled trial

    The Live Well with Parkinson’s Self-Management Toolkit is designed for use in the NHS to support people with Parkinson’s, their carers and health professionals in managing motor and non-motor symptoms and prom...

    Kate Walters, Megan Armstrong, Benjamin Gardner, Gareth Ambler, Rachael Hunter in Trials (2023)

  7. Article

    Open Access

    The experience of Anxiety for people with Parkinson’s disease

    Anxiety is a common non-motor symptom of Parkinson’s disease (PD) associated with increased disability and reduced quality of life. However, anxiety is poorly understood, underdiagnosed, and undertreated. To d...

    Emma. K. Blundell, Laura. E. Grover, Joshua Stott, Anette Schrag in npj Parkinson's Disease (2023)

  8. Article

    Open Access

    Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

    Tourette Syndrome (TS) is a complex neurodevelopmental disorder characterized by vocal and motor tics lasting more than a year. It is highly polygenic in nature with both rare and common previously associated ...

    Pritesh Jain, Tyne Miller-Fleming, Apostolia Topaloudi in Translational Psychiatry (2023)

  9. Article

    Open Access

    Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study

    This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities. This cross-sectional study compared serum 25-hydroxyvitamin D...

    Molly Bond, Natalie Moll, Alicia Rosello in European Child & Adolescent Psychiatry (2022)

  10. Article

    Open Access

    The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England

    Parkinson’s disease is a progressive neurodegenerative disease, which significantly impacts patients’ quality of life and is associated with high treatment and direct healthcare costs. In England, levodopa/car...

    K. Ray Chaudhuri, A. Simon Pickard, Ali Alobaidi, Yash J. Jalundhwala in PharmacoEconomics (2022)

  11. Article

    Open Access

    Change in the incidence of Parkinson’s disease in a large UK primary care database

    Parkinson’s disease (PD) has the fastest rising prevalence of all neurodegenerative diseases worldwide. However, it is unclear whether its incidence has increased after accounting for age and changes in diagno...

    Olaitan Okunoye, Louise Marston, Kate Walters, Anette Schrag in npj Parkinson's Disease (2022)

  12. Article

    Open Access

    Systematic review and meta-analysis of clinical effectiveness of self-management interventions in Parkinson’s disease

    Parkinson’s disease is a complex neurodegenerative condition with significant impact on quality of life (QoL), wellbeing and function. The objective of this review is to evaluate the clinical effectiveness of ...

    Jennifer S. Pigott, Edward J. Kane, Gareth Ambler, Kate Walters in BMC Geriatrics (2022)

  13. Article

    Open Access

    Develo** and assessing a new web-based tap** test for measuring distal movement in Parkinson’s disease: a Distal Finger Tap** test

    Disability in Parkinson’s disease (PD) is measured by standardised scales including the MDS-UPDRS, which are subject to high inter and intra-rater variability and fail to capture subtle motor impairment. The B...

    Noreen Akram, Haoxuan Li, Aaron Ben-Joseph, Caroline Budu in Scientific Reports (2022)

  14. Article

    Open Access

    Health care professionals’ perspectives on self-management for people with Parkinson’s: qualitative findings from a UK study

    Parkinson’s disease is a long-term, complex health condition. To improve or maintain quality of life, people with Parkinson’s can have an active involvement in their care through self-management techniques. Gi...

    Megan Armstrong, Remco Tuijt, Joy Read, Jennifer Pigott, Nathan Davies in BMC Geriatrics (2021)

  15. Article

    Open Access

    Identifying Parkinson’s disease subtypes with motor and non-motor symptoms via model-based multi-partition clustering

    Identification of Parkinson’s disease subtypes may help understand underlying disease mechanisms and provide personalized management. Although clustering methods have been previously used for subty**, they h...

    Fernando Rodriguez-Sanchez, Carmen Rodriguez-Blazquez, Concha Bielza in Scientific Reports (2021)

  16. Article

    Open Access

    Resource Utilization of Patients with Parkinson’s Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study

    The Care of Late-Stage Parkinsonism (CLaSP) study aimed to collect qualitative and standardized patient data in six European countries (France, Germany, Netherlands, Portugal, UK, Sweden) to enable a detailed ...

    Christopher Kruse, Sabrina Kretschmer, Anna Lipinski, Malte Verheyen in PharmacoEconomics (2021)

  17. Article

    Open Access

    Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Gregory M. Pontone, Nadeeka Dissanayaka, Liana Apostolova in npj Parkinson's Disease (2020)

  18. Article

    Open Access

    Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease

    Anxiety is a severe problem for at least one-third of people living with Parkinson’s disease (PD). Anxiety appears to have a greater adverse impact on quality of life than motor impairment. Despite its high pr...

    Gregory M. Pontone, Nadeeka Dissanayaka, Liana Apostolova in npj Parkinson's Disease (2019)

  19. No Access

    Article

    Neuropsychiatric aspects of Parkinson’s disease

    Throughout the natural history of Parkinson’s Disease (PD), from the pre-diagnostic phase to end stage disease, neuropsychiatric manifestations represent a core feature of the disease. This review summarises c...

    Anna Nagy, Anette Schrag in Journal of Neural Transmission (2019)

  20. No Access

    Article

    Dyskinesia in multiple system atrophy and progressive supranuclear palsy

    In the differential diagnosis of Parkinson syndromes, the response to l-Dopa is an essential criterion for the diagnosis of idiopathic Parkinson’s syndrome (IPS), and the presence of l-Dopa-induced dyskinesia (LI...

    Wolfgang H. Jost, Paul Lingor, Lars Tönges in Journal of Neural Transmission (2019)

previous disabled Page of 2